Article Per Year (5 Year)
p-Index From 2019 - 2024
0
P-Index
This Author published in this journals
All Journal Indonesian Journal of Tropical and Infectious Disease
William Kamarullah
Faculty of Medicine, Atma Jaya Catholic University of Indonesia
Earth & Planetary Sciences Health Professions Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
POTENCY OF LUTEOLIN WITH SOLID LIPID NANOPARTICLE (SLN)-POLYETHYLENE GLYCOL (PEG) MODIFICATION FOR ARTEMISININ-RESISTANT PLASMODIUM FALCIPARUM INFECTION William Kamarullah; Erika Indrajaya; Janice Emmanuella
Indonesian Journal of Tropical and Infectious Disease Vol. 7 No. 3 (2018)
Publisher : Institute of Topical Disease Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (535.493 KB) | DOI: 10.20473/ijtid.v7i3.6726

Abstract

Falciparum malaria is still considered as one of the important global health problems and its causal agent (Plasmodium falciparum) is reported to be the third most common factor for contributing the number of deaths in the world. As we all know, Artemisinins arethe most rapidly acting of currently available antimalarial drugs. Along with Artesunate, these two combining drugs, the so-called Artemisinin-based combination therapies (ACTs) has become the foundation of modern falciparum malaria treatment globally. Nowadays, however, there have been reports about intricate cases of resistance against Artemisinin in various Southeast Asian countries and it is predicted to spread over several other countries, including Indonesia. Therefore, adjuvant therapy is required along with first-line therapy administration to help eradicate both Artemisinin-sensitive and resistant P. falciparum. Luteolin in vitro has a prospective inhibitory activity (IC50<50 μg) in inhibiting the development of parasite’s life cycle. Nonetheless, its poor bioavailability and pharmacokinetics restrict clinical application. The low bioavailability of luteolin requires encapsulation using solid lipid nanoparticle (SLN) and polyethylene glycol (PEG). SLN is useful for improving the bioavailability of luteolin in the body, whereas PEG is needed in order to prevent the destruction of luteolin-SLN substance by the reticuloendothelial system. Here in this literature review, we’re trying to demonstrate the benefits, potential, way of constructions, pharmacokinetics, and pharmacodynamics of luteolin encapsulated with SLN with PEG modification. Thus, it is hoped that the results of this literature study may encourage further research in assisting the development of adjuvant therapy for cases of Artemisinin-resistant P. falciparum infection.
Co-Authors Erika Indrajaya Janice Emmanuella